SSTR5 and pancreatic insulinoma: The inadequate control of insulin secretion by somatostatin analogs is probably a consequence of the low expression of SSTR2 and SSTR5 in insulinomas, which also explains the reason for the low percentage of SPECT scintigraphy-positive tumors.